Carvedilol for portal hypertension in patients with cirrhosis.

Bosch J

首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Carvedilol for portal hypertension in patients with cirrhosis.

【24h】

Carvedilol for portal hypertension in patients with cirrhosis.

机译：卡维地洛用于肝硬化患者的门静脉高压症。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Portal hypertension is an almost unavoidable complication of cirrhosis, and provides the driving force for most of its complications, such as esophageal and gastric varices, variceal bleeding, portal hypertensive gastropathy, ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, thrombopenia, leukopenia and anemia, and portal-systemic encephalopathy.

机译：门静脉高压症是肝硬化几乎不可避免的并发症，并为其大多数并发症提供动力，例如食管和胃静脉曲张，静脉曲张破裂出血，门脉高压性胃病，腹水，自发性细菌性腹膜炎，肝肾综合征，血小板减少症，白细胞减少症和贫血，和门静脉系统性脑病。

著录项

来源
《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2010年第6期|共5页
作者
Bosch J;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Carvedilol for portal hypertension in patients with cirrhosis. [J] . Bosch J Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2010,第6期

机译：卡维地洛用于肝硬化患者的门静脉高压症。
2. The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis [J] . Sheng Chen, Jin-Jun Wang, Qin-Qin Wang, Patient Preference and Adherence . 2015,第2期

机译：卡维地洛和普萘洛尔对肝硬化门脉高压的影响：荟萃分析
3. The Sustained Virological Response (SVR) by Direct-acting antivirals agents (DAA) reduces portal hypertension in patients with HCV cirrhosis. [J] . Calvaruso Vincenza, Bonaccorso Ambra, Mogavero Giuseppe, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：通过直接作用抗病毒剂（DAA）的持续的病毒学反应（SVR）降低了HCV肝硬化患者的门静脉血高血压。
4. Investigation of Non-Invasive Attributes for Classification of Patients with Portal Hypertension [C] . Mindaugas Marozas, Romanas Zykus, Andrius Sakalauskas, Proceedings of 12th International Conference BIOMDLORE 2018 . 2018

机译：门静脉高压症患者非侵入性属性的分类研究
5. Elastography of the Spleen as an Acute Measure of Portal Hypertension in Patients with Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Systematic Review of the Literature and Future Directions [D] . King, Samantha. 2017

机译：脾脏的弹性显影作为患者术术肝内植物系统分流器（提示）患者门静脉高压的急性测量：对文献和未来方向的系统审查
6. The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis [O] . Sheng Chen, Jin-Jun Wang, Qin-Qin Wang, 2015

机译：卡维地洛和普萘洛尔对肝硬化门脉高压的影响：荟萃分析
7. Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis. [O] . Le Wang, Yuemin Feng, Xiaowen Ma, 2017

机译：无创肝纤维化指标对肝硬化门静脉高压症的诊断价值。

Carvedilol for portal hypertension in patients with cirrhosis.

摘要

著录项

相似文献

相关主题

期刊订阅